Science Daily

Study finds statins reduce the relative risk of cardiovascular diseases by over 20% in adults aged 75+ with high cholesterol

Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...
TCTMD

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

For patients with type 2 diabetes, a new study reinforces the importance of adhering to a healthy lifestyle even when taking a glucagon-like peptide-1 (GLP-1) receptor agonist. Patients who combined a ...
Medscape

In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event

NEW ORLEANS — The first global randomized trial of the PCSK9 inhibitor evolocumab for the prevention of a primary major adverse cardiovascular event (MACE) found a relative reduction in risk similar ...
The Motley Fool

What Is Risk Management: Principles & Techniques

Identify potential threats to optimize investment decisions and enhance security. Regularly evaluate and prioritize risks to focus on the most critical vulnerabilities. Employ diverse risk control ...
ascopubs.org

Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer

Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches A model of absolute risk ...